main-logo

ICD-10 Code D05.00 | Lobular carcinoma in situ of unspecified breast Symptoms, Diagnosis, Billing

Lobular carcinoma in situ (LCIS) of the breast is a non-invasive neoplasm characterized by abnormal cell growth in the lobules of the breast. While it is not considered breast cancer, it is a marker for increased risk of developing invasive breast cancer in the future. Accurate coding with ICD-10 Code D05.00 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate surveillance and management.

What is ICD-10 Code D05.00 for Lobular carcinoma in situ of unspecified breast?

ICD-10 Code D05.00 represents lobular carcinoma in situ of the unspecified breast, indicating the presence of abnormal lobular cells without invasion. This code is used in clinical documentation and billing when diagnosing patients with LCIS, which may require monitoring and preventive strategies due to its association with an elevated risk of invasive breast cancer.

ICD-10 Code D05.00 – Clinical Definition and Explanation of Lobular carcinoma in situ of unspecified breast

Lobular carcinoma in situ of unspecified breast is a condition where abnormal cells are found in the lobules of the breast. It is not invasive but indicates a higher risk for future breast cancer. Medical attention is necessary for appropriate management and surveillance.

Key Clinical Features:

  • Typically asymptomatic and discovered incidentally during breast imaging or biopsy.
  • Increased risk factor for developing invasive breast cancer later in life.
  • May present bilaterally in some patients.
  • Requires regular monitoring and potential preventive measures.

ICD-10 Code D05.00 for Lobular carcinoma in situ of unspecified breast – SOAP Notes & Clinical Use

ICD-10 Code D05.00 is utilized in SOAP notes to document the diagnosis of lobular carcinoma in situ, aiding in the assessment of patient history, clinical findings, and treatment plans. It is relevant in both acute and chronic care settings for comprehensive patient management.

What Does ICD-10 Code D05.00 for Lobular carcinoma in situ of unspecified breast Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D05.00 connects subjective patient reports and objective clinical findings to a formal diagnosis of lobular carcinoma in situ. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code D05.00 – Lobular carcinoma in situ of unspecified breast

Management of lobular carcinoma in situ may not require immediate intervention but necessitates careful monitoring and preventive strategies.

Antibiotic Therapy:

    Supportive Care:

    • Regular breast imaging (e.g., mammograms, MRI) for surveillance.
    • Genetic counseling if there is a family history of breast cancer.
    • Discussion of preventive mastectomy or chemoprevention options.

    Infection Control:

      How to Document Symptoms of Lobular carcinoma in situ of unspecified breast (ICD-10 D05.00) in SOAP Notes

      Subjective:

      • Patient reports no breast lumps or pain.
      • Family history of breast cancer noted.
      • Patient expresses concern about future breast cancer risk.
      • No significant changes in breast appearance or discharge.

      Objective:

      • Mammogram shows no signs of invasive disease.
      • Breast examination reveals no palpable masses.
      • Biopsy confirms lobular carcinoma in situ.
      • No lymphadenopathy detected.
      card-topcard-bottom

      Secure, compliant, and built for trust

      HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

      Learn more
      hipaa-icon

      SOAP Note Guidelines for Diagnosing Lobular carcinoma in situ of unspecified breast (ICD-10 Code D05.00)

      Assessment:

      • Diagnosis: Lobular carcinoma in situ of unspecified breast, low risk for immediate progression.
      • ICD-10 Code: D05.00.
      • Contributing factors: Family history of breast cancer.

      Plan:

      • Schedule annual mammograms and MRI as indicated.
      • Refer for genetic counseling.
      • Discuss options for preventive measures with the patient.
      • Follow up in 6 months to reassess.

      Treatment & Plan Section for ICD-10 Code D05.00 – Lobular carcinoma in situ of unspecified breast

      • Regular surveillance with imaging studies.
      • Consideration of prophylactic surgery based on patient preference and risk assessment.
      • Patient education on breast self-exams and awareness of changes.
      • Monitoring for psychological impact and providing support resources.

      Using ICD-10 Code D05.00 for Lobular carcinoma in situ of unspecified breast in Billing & SOAP Note Compliance

      • Ensure accurate documentation of patient history and clinical findings.
      • Use D05.00 in settings where LCIS is diagnosed or monitored.
      • Align treatment plans with clinical guidelines to support billing.
      • Include relevant CPT codes for imaging and consultations.

      ICD-10 Code D05.00 in Medical Billing and Insurance for Lobular carcinoma in situ of unspecified breast

      ICD-10 Code D05.00 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims for services related to lobular carcinoma in situ.

      Billing Notes:

      • Document all relevant patient history and clinical findings to support the diagnosis.
      • Use D05.00 in conjunction with appropriate CPT codes for imaging and consultations.
      • Ensure compliance with payer guidelines for documentation and coding.
      • Review coding updates regularly to maintain accuracy.

      Common CPT Pairings:

      CPT CodeDescription
      77067Mammography, bilateral, including computer-aided detection.
      88305Pathology examination of breast tissue.
      99214Established patient office visit, moderate complexity.

      Frequently Asked Questions

      Common Questions About Using ICD-10 Code D05.00 for Lobular carcinoma in situ of unspecified breast

      What is lobular carcinoma in situ?

      Lobular carcinoma in situ (LCIS) is a non-invasive condition where abnormal cells are found in the lobules of the breast. It is not cancer but indicates an increased risk for developing invasive breast cancer in the future.

      How is lobular carcinoma in situ diagnosed?

      LCIS is typically diagnosed through breast imaging, such as mammograms or MRIs, followed by a biopsy that confirms the presence of abnormal lobular cells.

      What are the treatment options for lobular carcinoma in situ?

      Management of LCIS often involves regular monitoring with imaging studies, genetic counseling, and discussions about preventive measures, including lifestyle changes or prophylactic surgery.

      Is lobular carcinoma in situ a form of breast cancer?

      No, lobular carcinoma in situ is not considered breast cancer. However, it is a marker for increased risk of developing invasive breast cancer later in life.

      diamond-bg
      diamond-bg

      Get started with your 20 free notes

      Sign up for free
      main-logo

      AI-aided Sudsy Shorthand for ink-free practices

      support@soapsuds.io
      hipaa-logo

      Clinical Notes

      SOAP notes

      DAP notes

      AI medical notes

      © Copyright SOAPsuds 2025. All rights reserved